AnaptysBio
ANAB
ANAB
116 hedge funds and large institutions have $2.39B invested in AnaptysBio in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 41 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
63% more funds holding
Funds holding: 71 → 116 (+45)
44% more call options, than puts
Call options by funds: $20.4M | Put options by funds: $14.2M
14% more ownership
Funds ownership: 87.17% → 101.17% (+14%)
Holders
116
Holding in Top 10
7
Calls
$20.4M
Puts
$14.2M
Top Buyers
| 1 | +$146M | |
| 2 | +$114M | |
| 3 | +$107M | |
| 4 |
BlackRock
New York
|
+$71.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$52.2M |
Top Sellers
| 1 | -$79M | |
| 2 | -$41.6M | |
| 3 | -$22.8M | |
| 4 |
Millennium Management
New York
|
-$14.8M |
| 5 |
JP Morgan Chase
New York
|
-$11.3M |